iPSC Processing Core

$326,005P01FY2025HLNIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39515331 Paper 39413786 Paper 39340505 Paper 39170365 Paper 38895350 Paper 38798547 Paper 38659841 Paper 38359791 Paper 38100909 Paper 38099847 Paper 38012305 Paper 37961889 Paper 37788558 Paper 37693816 Paper 37662205 Paper 37624096 Paper 37555352 Paper 37523735 Paper 37293707 Paper 37166736 Paper 37149124 Paper 37119139 Paper 36927079 Paper 36745700 Paper 36744541 Paper 36696485 Paper 36662864 Paper 36642055 Paper 36607801 Paper 36563695 Paper 36528013 Paper 36487186 Paper 36332467 Paper 36305844 Paper 36270069 Paper 36255053 Paper 36227145 Paper 36194907 Paper 36172952 Paper 36167075 Paper 36114707 Paper 36094888 Paper 36018047 Paper 35944901 Paper 35853412 Paper 35788685 Paper 35775488 Paper 35763671 Paper 35728000 Paper 35700631 Paper 35620477 Paper 35606425 Paper 35482009 Paper 35464087 Paper 35413566 Paper 35411324 Paper 35405106 Paper 35370783 Paper 35344407 Paper 35036877 Paper 34999423 Paper 34788089 Paper 34648073 Paper 34411974 Paper 34371035 Paper 34352619 Paper 34326268 Paper 34279605 Paper 34260402 Paper 34073281 Paper 34051449 Paper 34045974 Paper 33963531 Paper 33928785 Paper 33926209 Paper 33816571 Paper 33772748 Paper 33743363 Paper 33743362 Paper 33740432 Paper 33731358 Paper 33647311 Paper 33615277 Paper 33601939 Paper 33590335 Paper 33542270 Paper 33503403 Paper 33483728 Paper 33375812 Paper 33334123 Paper 33237428 Paper 33183171 Paper 33074758 Paper 32931730 Paper 32905764 Paper 32821022 Paper 32763147 Paper 32697997 Paper 32668256 Paper 32667679

Abstract

PROJECT SUMMARY (CORE B - iPSC Biobank Core): The Core B serves as a critical pillar in the collective efforts of this Program Project. Its central mission is to support and empower all projects and cores by providing essential resources, infrastructure, and expertise focused on induced pluripotent stem cells (iPSCs) and their pivotal role in unraveling the intricacies of cardiotoxicity associated with cancer therapeutics.

View original record on NIH RePORTER →